CSTONE PHARMA-B News

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 3,345,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 7,529,500 SHARES

00:00 ET

CSTONE PHARMA-B: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

Apr 23 05:01 ET

CSTONE PHARMA-B: 2023 ANNUAL REPORT

Apr 23 05:00 ET

CSTONE PHARMA-B: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION

Apr 15 05:02 ET

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE ACCEPTANCE OF RET INHIBITOR GAVRETO (PRALSETINIB) MANUFACTURING LOCALIZATION APPLICATION BY CENTER FOR DRUG EVALUATION OF CHINA NMPA

Apr 8 20:00 ET

CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

Apr 5 04:30 ET

CSTONE PHARMA-B: (I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP

Mar 28 10:45 ET

CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

Mar 27 08:43 ET

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE FIFTH INDICATION APPROVED FOR SUGEMALIMAB IN CHINA AS FIRST-LINE TREATMENT OF GASTRIC CANCER

Mar 15 00:00 ET

CSTONE PHARMA-B: DATE OF BOARD MEETING

Mar 14 05:00 ET

CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

Mar 6 03:30 ET

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT

Mar 3 23:27 ET

CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

Feb 6 06:01 ET

CSTONE PHARMA-B: LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS

Jan 23 04:06 ET

CSTONE PHARMA-B: LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS

Jan 23 04:00 ET

CSTONE PHARMA-B: POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 17, 2024

Jan 17 06:58 ET

CSTONE PHARMA-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023

Jan 5 05:41 ET

CSTONE PHARMA-B: FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING

Dec 28, 2023 04:09 ET

CSTONE PHARMA-B: NOTICE OF EXTRAORDINARY GENERAL MEETING

Dec 28, 2023 04:05 ET

CSTONE PHARMA-B: (1) PROPOSED GRANT OF OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP; (2) NOTICE OF EXTRAORDINARY GENERAL MEETING; AND (3) CLOSURE OF REGISTER OF MEMBERS FOR THE EXTRAORDINARY GENERAL MEETING

Dec 28, 2023 04:00 ET